Company intelligence / Profile preview

Auritec Pharmaceuticals, Inc.

Santa Monica, California, United Statespitchbook.com ↗

Ownership: Private
Employees: ~9
Development stage: Phase 1

Overview

Auritec has demonstrated success in developing sustained-release formulations that improve therapeutic profiles of existing drugs. Their SR-TAC program aims to reduce toxicity and improve adherence in organ transplant patients by providing subcutaneous extended release of tacrolimus. The Phase I trial was completed successfully with healthy volunteers[6]. The company has continuous NIH funding supporting multiple programs across various indications[1][2].

Therapeutic areas: CardiovascularPsychiatryImmunologyWomen's HealthNeurologyInfectious Diseases
Modalities: Sustained-release drug delivery systemsExtended release formulationsDrug delivery technologies including Versa, Plexis, Co-drugs/Pro-drugs platformsSmall molecules (e.g., tacrolimus)
Industry: Biotech

Drug pipeline

1 asset

SR-TAC

Unknown

Partnerships

No major pharmaceutical partnerships explicitly listed publicly. Continuous funding from National Institutes of Health is a key support source[1][2].

Beyond the preview

Go deeper on Auritec Pharmaceuticals, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Auritec Pharmaceuticals, Inc..

Explore the full profile